Dublin, July 28, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Prenatal Diagnostics - Global Strategic Business Report" report to their offering.
This report analyzes the worldwide markets for Prenatal Diagnostics in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.
Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
The report profiles 43 companies including many key and niche players such as
- ANGLE Plc. (UK)
- Ariosa Diagnostics, Inc. (US)
- BGI Diagnosis Co., Ltd. (China)
- Berry Genomics Co., Ltd. (China)
- Hologic, Inc. (US)
- Illumina, Inc. (US)
- Laboratory Corporation of America® Holdings (US)
- Lifecodexx AG (Germany)
- Natera, Inc. (US)
- Quest Diagnostics, Inc. (US)
- Ravgen, Inc. (US)
- Sequenom, Inc. (US)
- Sequenom Center for Molecular Medicine, LLC (US)
- TrovaGene, Inc. (US)
Key Topics Covered:
1. Industry Overview
2. Growth Drivers & Market Trends
3. Competitive Environment
4. Product Overview
5. Product Innovations/Launches
6. Recent Industry Activity
7. Focus On Select Global Players
8. Global Market Perspective
Total Companies Profiled: 43 (including Divisions/Subsidiaries 44)
- The United States (19)
- Europe (17)
- - France (1)
- - Germany (2)
- - The United Kingdom (4)
- - Spain (1)
- - Rest of Europe (9)
- Asia-Pacific (Excluding Japan) (6)
- Middle-East (2)
For more information visit http://www.researchandmarkets.com/research/kfh3cs/prenatal